source
- Merck stages expanded access to monthly HIV PrEP pill ahead of approvalFollowing in the footsteps of Gilead, Merck has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir ahead of any regulatory submissions.Fierce Biotech · 6d ago↗ source
- Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyoutSanofi has abandoned plans to seek approval for amlitelimab in atopic dermatitis, admitting that a drug once tipped as a potential blockbuster “would not represent a meaningful improvement” to exis…Fierce Biotech · 6d ago↗ source
- Early Alert: Percutaneous Catheter Issue from Boston ScientificENROUTE Transcarotid Neuroprotection Systems may have arterial sheath tip separation or partial tip separation during use